Bortezomib (a proteasome inhibitor) has recently been approved for treatment of relapsed multiple myeloma, a plasma cell neoplasia, owing to the sensitivity of immunoglobulin-synthesizing myeloma ...

BORUZU, the first ready-to-use version of bortezomib, is a proteasome inhibitor indicated to treat multiple myeloma and ...

The study is evaluating belantamab mafodotin in combination with bortezomib plus dexamethasone, or BVd, versus daratumumab in combination with bortezomib plus dexamethasone, or DVd, as a second ...

Suggested remit: To appraise the clinical and cost effectiveness of daratumumab with bortezomib, lenalidomide and dexamethasone within its marketing authorisation for untreated multiple myeloma when ...

Discover all the brand names or Trade names of generic drug called Bortezomib. This serves as a crucial reference for healthcare professionals, patients, caregivers, and anyone looking to ...